142 related articles for article (PubMed ID: 30826566)
1. CYP2C19*2 polymorphism in Polish peptic ulcer patients.
Sałagacka-Kubiak A; Żebrowska-Nawrocka M; Jeleń A; Mirowski M; Balcerczak E
Pharmacol Rep; 2019 Apr; 71(2):272-275. PubMed ID: 30826566
[TBL] [Abstract][Full Text] [Related]
2. Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer.
Jainan W; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(24):10957-60. PubMed ID: 25605208
[TBL] [Abstract][Full Text] [Related]
3. Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients.
Kurzawski M; Gawrońska-Szklarz B; Wrześniewska J; Siuda A; Starzyńska T; Droździk M
Eur J Clin Pharmacol; 2006 Oct; 62(10):877-80. PubMed ID: 16912869
[TBL] [Abstract][Full Text] [Related]
4. Investigation of -308G>A and -1031T>C polymorphisms in the TNFA promoter region in Polish peptic ulcer patients.
Sałagacka A; Żebrowska M; Jeleń A; Mirowski M; Balcerczak E
Gut Liver; 2014 Nov; 8(6):632-6. PubMed ID: 25368751
[TBL] [Abstract][Full Text] [Related]
5. The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
Sapone A; Vaira D; Trespidi S; Perna F; Gatta L; Tampieri A; Ricci C; Cantelli-Forti G; Miglioli M; Biagi GL; Paolini M
Am J Gastroenterol; 2003 May; 98(5):1010-5. PubMed ID: 12809821
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the host CYP2C19 gene and antibiotic-resistance attributes of Helicobacter pylori isolates influence the outcome of triple therapy.
Ram M R; Teh X; Rajakumar T; Goh KL; Leow AHR; Poh BH; Mariappan V; Shankar EM; Loke MF; Vadivelu J
J Antimicrob Chemother; 2019 Jan; 74(1):11-16. PubMed ID: 30403784
[TBL] [Abstract][Full Text] [Related]
7. Assessment of TNFA polymorphisms at positions -857 and -863 in Polish peptic ulcer patients.
Sałagacka-Kubiak A; Zebrowska M; Jeleń A; Mirowski M; Balcerczak E
Adv Med Sci; 2016 Mar; 61(1):164-8. PubMed ID: 26774268
[TBL] [Abstract][Full Text] [Related]
8. Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer.
Lay CS; Lin CJ
J Chin Med Assoc; 2010 Apr; 73(4):188-93. PubMed ID: 20457439
[TBL] [Abstract][Full Text] [Related]
9. Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
Inaba T; Mizuno M; Kawai K; Yokota K; Oguma K; Miyoshi M; Take S; Okada H; Tsuji T
J Gastroenterol Hepatol; 2002 Jul; 17(7):748-53. PubMed ID: 12121503
[TBL] [Abstract][Full Text] [Related]
10. C3435T polymorphism of the ABCB1 gene: impact on genetic susceptibility to peptic ulcers.
Sałagacka A; Bartczak M; Zebrowska M; Jażdżyk M; Balcerczak M; Janiuk R; Mirowski M; Balcerczak E
Pharmacol Rep; 2011; 63(4):992-8. PubMed ID: 22001987
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Furuta T; Shirai N; Xiao F; El-Omar EM; Rabkin CS; Sugimura H; Ishizaki T; Ohashi K
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):22-30. PubMed ID: 15017629
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial.
Yoshizawa Y; Sugimoto M; Sato Y; Sahara S; Ichikawa H; Kagami T; Hosoda Y; Kimata M; Tamura S; Kobayashi Y; Osawa S; Sugimoto K; Miyajima H; Furuta T
Dig Endosc; 2016 Mar; 28(2):162-72. PubMed ID: 26331711
[TBL] [Abstract][Full Text] [Related]
13. Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection.
Ohtaka Y; Azuma T; Konishi J; Ito S; Kuriyama M
Gut; 1997 Oct; 41(4):469-74. PubMed ID: 9391244
[TBL] [Abstract][Full Text] [Related]
14. Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication.
Karaca RO; Kalkisim S; Altinbas A; Kilincalp S; Yuksel I; Goktas MT; Yasar U; Bozkurt A; Babaoglu MO
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):199-206. PubMed ID: 27611887
[TBL] [Abstract][Full Text] [Related]
15. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
[TBL] [Abstract][Full Text] [Related]
16. [THE EFFECTIVENESS OF ERADICATION IN PATIENTS WITH PEPTIC ULCER DISEASE ASSOCIATED WITH HELICOBACTER PYLORI, DEPENDING ON THE GENOTYPE OF THE DRUGMETABOLISM OF PROTON PUMP INHIBITORS].
Elokhina EV; Kostenko MB; Livzan MA; Scalskiy SV
Eksp Klin Gastroenterol; 2015; (3):31-3. PubMed ID: 26281174
[TBL] [Abstract][Full Text] [Related]
17. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection.
Gawrońska-Szklarz B; Wrześniewska J; Starzyńska T; Pawlik A; Safranow K; Ferenc K; Droździk M
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):375-9. PubMed ID: 15976989
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Inaba T; Yamamoto K; Okada H; Yokota K; Oguma K; Shiratori Y
Am J Gastroenterol; 2003 Nov; 98(11):2403-8. PubMed ID: 14638340
[TBL] [Abstract][Full Text] [Related]
19. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.
Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Sugimura H; Hishida A; Ishizaki T
Aliment Pharmacol Ther; 2005 Nov; 22(10):1033-40. PubMed ID: 16268979
[TBL] [Abstract][Full Text] [Related]
20. Association of Helicobacter pylori infection with Toll-like receptor-4 Thr399Ile polymorphism increased the risk of peptic ulcer development in North of Iran.
Tourani M; Habibzadeh M; Shokri-Shirvani J; Teymournejad O; Mostafazadeh A; Khafri S; Nouri HR
APMIS; 2018 Jan; 126(1):76-84. PubMed ID: 29135054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
